The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Floyd, Christopher N ^a   Ellis, Benjamin H ^a   Ferro, Albert ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IIIA; BETA3 INTEGRIN;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CEREBROVASCULAR ACCIDENT; DNA POLYMORPHISM; GENE; GENE FREQUENCY; GENETIC HETEROGENEITY; HOMOZYGOSITY; HUMAN; INCIDENCE; PLA2 GENE; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; ALLELE; FEMALE; GENETIC POLYMORPHISM; GENETICS; HOMOZYGOTE; MALE; MEDLINE; META ANALYSIS; STROKE;

ADOLESCENT; ADULT; ALLELES; BRAIN ISCHEMIA; FEMALE; HOMOZYGOTE; HUMANS; INTEGRIN BETA3; MALE; MEDLINE; POLYMORPHISM, GENETIC; RISK FACTORS; STROKE;

EID: 84903766717     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100239     Document Type: Article

References (82)

1. Broos K, Feys HB, De Meyer SF, Vanhoorelbeke K, Deckmyn H (2011) Platelets at work in primary hemostasis. Blood Reviews 25: 155-167.
2. Floyd CN, Ferro A (2012) The platelet fibrinogen receptor: from megakaryocyte to the mortuary. Journal of the Royal Society of Medicine Cardiovascular Disease. pp. 1-13.
3. Bennett JS (2005) Structure and function of the platelet integrin alpha(IIb)-beta(3). Journal of Clinical Investigation 115: 3363-3369.
4. Newman PJ, Valentin N (1995) Human platelet alloantigens: recent findings, new perspectives. Thromb Haemost 74: 234-239.
5. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, et al. (1996) A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334: 1090-1094. (Pubitemid 26120186)
6. Floyd CN, Mustafa A, Ferro A (2014) The PlA1/A2 polymorphisms of glycoprotein IIIa as an age-dependent risk factor for myocardial infarction: a meta-analysis. J Am Coll Cardiol 63: 12-S.
7. Kannel WB (1994) Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1: 333-339.
8. Dichgans M (2007) Genetics of ischaemic stroke. Lancet Neurol 6: 149-161.
9. Cheng YC, Anderson CD, Bione S, Keene K, Maguire JM, et al. (2012) Are myocardial infarction-associated single-nucleotide polymorphisms associated with ischemic stroke? Stroke 43: 980-986.
10. Bentley P, Peck G, Smeeth L, Whittaker J, Sharma P (2010) Causal Relationship of Susceptibility Genes to Ischemic Stroke: Comparison to Ischemic Heart Disease and Biochemical Determinants. Plos One 5.
11. Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 265: 2037-2048. (Pubitemid 24325685)
12. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
13. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
14. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to Meta-Analysis John Wiley & Sons, Ltd.
15. Deeks JJ (2001) Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323: 157-162.
16. Higgins JPT, Green S (2008) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0: The Cochrane Collaboration.
17. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
18. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Bene J, et al. (2003) Increased prevalence of platelet glycoprotein IIb/IIIa PLA2 allele in ischaemic stroke associated with large vessel pathology. Thrombosis Research 109: 265-269. (Pubitemid 36724820)
19. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K (1997) Pl(A1/A2) polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349: 385-388. (Pubitemid 27077666)
20. Ishii K, Murata M, Oguchi S, Takeshita E, Ito D, et al. (2004) Genetic risk factors for ischemic cerebrovascular disease-analysis on fifteen candidate prothrombotic gene polymorphisms in the Japanese population. Rinsho byori The Japanese journal of clinical pathology 52: 22-27.
21. Oksala NKJ, Heikkinen M, Mikkelsson J, Pohjasvaara T, Kaste M, et al. (2007) Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA Pl(A1/A2) polymorphism interact in the risk of lacunar stroke and midterm survival. Stroke 38: 50-55. (Pubitemid 46035605)
22. Golenia A, Adamski M, Wnuk M, Szczygiel E, Juchniewicz K, et al. (2009) A1/A2 polymorphism of GpIIIa gene and a risk of aneurysmal subarachnoid haemorrhage. European Journal of Neurology 16: 289-289.
23. Saidi S, Mahjoub T, Slamia LB, Ammou SB, Al-Subaie AM, et al. (2008) Association of human platelet alloantigen 1 through 5 polymorphisms with ischemic stroke. Cerebrovascular Diseases 25: 81-86. (Pubitemid 351280379)
24. De Rosa R, Galasso G, Piscione F, Santulli G, Iaccarino G, et al. (2010) Increased risk of cardiovascular events associated with the GPIIIA PlA2 polymorphism. Cardiovascular Research 87: S74-S75.
25. Elalamy I, Chakroun T, Addad F, Dridi Z, Abderrazak F, et al. (2009) Platelet glycoprotein IIB/IIIA polymorphism and risk of cardiovascular events in aspirin-treated patients with stable coronary artery disease. 22nd Congress of the International Society of Thrombosis and HaemostasisBoston, MA United States.: Journal of Thrombosis and Haemostasis.
26. Biswas A, Ranjan R, Meena A, Akhter S, Sharma V, et al. (2009) Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. Thrombosis Research 124: 397-402.
27. Maguire J, Thakkinstian A, Levi C, Lincz L, Bisset L, et al. (2011) Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 Polymorphisms on 90-Day Ischemic Stroke Functional Outcome: A Novel Finding. Journal of Stroke & Cerebrovascular Diseases 20: 134-144.
28. Pruissen DMO, Kappelle LJ, Rosendaal FR, Algra A, Grp SS (2009) Prothrombotic genetic variants and atherosclerosis in patients with cerebral ischemia of arterial origin. Atherosclerosis 204: 191-195.
29. Adamski MG, Borratynska A, Krupa M, Wloch-Kopec D, Turaj W, et al. (2009) A1/A2 polymorphism of GpIIIa gene and a risk of aneurysmal subarachnoid haemorrhage. Biochemical and Biophysical Research Communications 383: 228-230.
30. Berge E, Haug KBF, Sandset EC, Haugbro KK, Turkovic M, et al. (2007) The factor v leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation. Stroke 38: 1069-1071. (Pubitemid 46568476)
31. Carter AM, Catto AJ, Bamford JM, Grant PJ (1998) Platelet GP IIIa PIA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arteriosclerosis Thrombosis and Vascular Biology 18: 1124-1131. (Pubitemid 28323597)
32. Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C (1997) Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke 28: 1392-1395. (Pubitemid 27300676)
33. Coelho FF, Fernandes AP, Gomes KB, Miranda CG, Carvalho MG, et al. Analysis of the association between the polymorphism PLA1/A2 of the platelet glycoprotein IIB/IIIA gene and the risk of ischemic stroke in young patients. var.pagings; 2009; Boston, MA, United States. pp. 434-435.
34. Corral J, GonzalezConejero R, Rivera J, Iniesta JA, Lozano ML, et al. (1997) HPA-1 genotype in arterial thrombosis - role of HPA-1b polymorphism in platelet function. Blood Coagulation & Fibrinolysis 8: 284-290.
35. Iniesta JA, Corral J, Gonzalez-Conejero R, Piqueras C, Vicente V (2003) Polymorphisms of platelet adhesive receptors: Do they play a role in primary intracerebral hemorrhage? Cerebrovascular Diseases 15: 51-55. (Pubitemid 36131898)
36. Iniesta JA, Gonzalez-Conejero R, Piqueras C, Vicente V, Corral J (2004) Platelet GP IIIa polymorphism HPA-1 (PlA) protects against subarachnoid hemorrhage. Stroke 35: 2282-2286. (Pubitemid 39311250)
37. Kekomaki S, Hamalainen L, Kauppinen-Makelin R, Palomaki H, Kaste M, et al. (1999) Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. Journal of Cardiovascular Risk 6: 13-17. (Pubitemid 29170058)
38. Lanni F, Santulli G, Izzo R, Rubattu S, Zanda B, et al. (2007) The PIA1/A2 polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. Journal of Hypertension 25: 551-556. (Pubitemid 46213792)
39. Meiklejohn DJ, Vickers MA, Morrison ER, Dijkhuisen R, Moore I, et al. (2001) In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib. British Journal of Haematology 112: 621-631. (Pubitemid 32222832)
40. Reiner AP, Kumar PN, Schwartz SM, Longstreth WT, Pearce RM, et al. (2000) Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 31: 1628-1633. (Pubitemid 30437514)
41. Roldan V, Marin F, Gonzalez-Conejero R, Garcia-Honrubia A, Marti S, et al. (2008) Factor VII-323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk. Annals of Medicine 40: 553-559.
42. Rubattu S, Speranza R, Ferrari M, Evangelista A, Beccia M, et al. (2005) A role of TNF-alpha gene variant on juvenile ischemic stroke: A case-control study. European Journal of Neurology 12: 989-993. (Pubitemid 41820054)
43. Rubattu S, Di Angelantonio E, Nitsch D, Gigante B, Zanda B, et al. (2005) Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population. Thrombosis and Haemostasis 93: 1095-1100. (Pubitemid 40823514)
44. Saidi S, Mahjoub T, Slamia LB, Ammou SB, Al-Subaie AM, et al. (2008) Polymorphisms of the human platelet alloantigens HPA-1, HPA-2, HPA-3, and HPA-4 in ischemic stroke. American Journal of Hematology 83: 570-573. (Pubitemid 351874874)
45. Slowik A, Dziedzic T, Turaj W, Pera J, Glodzik-Sobanska L, et al. (2004) A2 alelle of GpIIIa gene is a risk factor for stroke caused by large-vessel disease in males. Stroke 35: 1589-1593. (Pubitemid 38823630)
46. van Goor M, Garcia EG, Brouwers GJ, Leebeek FWG, Koudstaal PJ, et al. (2002) PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke. Thrombosis Research 108: 63-65. (Pubitemid 36197664)
47. Wagner KR, Giles WH, Johnson CJ, Ou CY, Bray PF, et al. (1998) Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk - The stroke prevention in young women study. Stroke 29: 581-585. (Pubitemid 28145782)
48. Zhang Y, Wang Y, Wang Y, Cui C, Huang P, et al. (2007) Platelet glycoprotein polymorphisms: Risk, in vivo expression and severity of atherothrombotic stroke in Chinese. Clinica Chimica Acta 378: 99-104. (Pubitemid 46241067)
49. Galasso G, Santulli G, Piscione F, De Rosa R, Trimarco V, et al. (2010) The GPIIIA PIA2 polymorphism is associated with an increased risk of cardiovascular adverse events. Bmc Cardiovascular Disorders 10.
50. Mustaffa R, Rifin MS, Hassan R, Mahmood WWH, Ghazali S (2009) Human platelet specific antigen (HPA-1) polymorphism in malay ischemic stroke patients. Vox Sanguinis 97: 128-128.
51. Streifler JY, Rosenberg N, Chetrit A, Eskaraev R, Sela BA, et al. (2001) Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 32: 2753-2758. (Pubitemid 33134459)
52. Pongracz E, Tordai A, Csornai M, Nagy Z (2001) Platelet glycoprotein IIb/IIIa (LeuPro 33) polymorphism in stroke patients. Orvosi hetilap 142: 781-785.
53. Castro V, Alberto FL, Costa RNP, Lepikson-Neto J, Gualandro SFM, et al. (2004) Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sanguinis 87: 118-123. (Pubitemid 39265460)
54. Komarov AL, Shakhmatova O, Rebrikov D, Kofiady I, Stambolsky D, et al. (2009) Haemostatic gene factors and risk of vascular events in Russian patients with stable coronary artery disease: The results of 4 years follow-up. 22nd Congress of the International Society of Thrombosis and Haemostasis. Boston, MA United States.
55. Yeh PS, Lin HJ, Li YH, Lin KC, Cheng TJ, et al. (2004) Prognosis of young ischemic stroke in Taiwan: Impact of prothrombotic genetic polymorphisms. Thrombosis and Haemostasis 92: 583-589.
56. Wei Y-s, Lan Y, Liu Y-g, Meng L-q, Xu Q-q, et al. (2009) Association of the integrin gene polymorphisms with ischemic stroke and plasma lipid levels. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 26: 211-215.
57. Addad F, Elalamy I, Chakroun T, Abderrazek F, Dridi Z, et al. (2010) Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease. Blood Coagul Fibrinolysis 21: 674-678.
58. Chen CH, Lo YK, Ke D, Liu CK, Liou CW, et al. (2004) Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa PlA1/A2 polymorphisms and ischemic stroke in young Taiwanese. Journal of the Neurological Sciences 227: 1-5. (Pubitemid 39491119)
59. Zhang Y, Wang Y, Cui C, Huang P, Li X, et al. (2007) Platelet glycoprotein polymorphisms: Risk, in vivo expression and severity of atherothrombotic stroke in Chinese. Clinica Chimica Acta 378: 99-104. (Pubitemid 46241067)
60. Li Q, Chen BL, Ozdemir V, Ji W, Mao YM, et al. (2007) Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin. Pharmacogenomics 8: 577-586. (Pubitemid 46939583)
61. Duan H, Cai Y, Sun X (2012) Platelet glycoprotein IIb/IIIa polymorphism HPA-3 b/b is associated with increased risk of ischemic stroke in patients under 60 years of age. Med Sci Monit 18: CR19-24.
62. Reuner KH, Elgas M, Kaps M, Ruf A, Patscheke H (1997) The human platelet antigen HPA-1a/1b (Pl(A1)/Pl(A2)) polymorphism and cerebral ischaemia. Thrombosis and Haemostasis 78: 964-965.
63. Iniesta JA, Corral J, Gonzalez-Conejero R, Rivera J, Vicente V (1999) Prothrombotic genetic risk factors in patients with coexisting migraine and ischemic cerebrovascular disease. Headache 39: 486-489. (Pubitemid 29400300)
64. Lalouschek W, Endler G, Schillinger M, Hsieh K, Lang W, et al. (2007) Candidate genetic risk factors of stroke: Results of a multilocus genotyping assay. Clinical Chemistry 53: 600-605. (Pubitemid 46580228)
65. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330: 1041-1046. (Pubitemid 24106561)
66. Tsai NW, Chang WN, Shaw CF, Jan CR, Chang HW, et al. (2009) Levels and value of platelet activation markers in different subtypes of acute non-cardioembolic ischemic stroke. Thromb Res 124: 213-218.
67. Kim WJ, Ko Y, Yang MH, Im SH, Park JH, et al. (2010) Differential effect of previous antiplatelet use on stroke severity according to stroke mechanism. Stroke 41: 1200-1204.
68. Sato Y, Ishibashi-Ueda H, Iwakiri T, Ikeda Y, Matsuyama T, et al. (2012) Thrombus components in cardioembolic and atherothrombotic strokes. Thromb Res 130: 278-280.
69. Vijayan KV, Huang TC, Liu Y, Bernardo A, Dong JF, et al. (2003) Shear stress augments the enhanced adhesive phenotype of cells expressing the Pro33 isoform of integrin beta3. FEBS Lett 540: 41-46. (Pubitemid 36398030)
70. Corral J, Gonzalez-Conejero R, Rivera J, Iniesta JA, Lozano ML, et al. (1997) HPA-1 genotype in arterial thrombosis-role of HPA-1b polymorphism in platelet function. Blood Coagul Fibrinolysis 8: 284-290. (Pubitemid 27360010)
71. Bennett JS, Catella-Lawson F, Rut AR, Vilaire G, Qi W, et al. (2001) Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets. Blood 97: 3093-3099.
72. Cheng C, Helderman F, Tempel D, Segers D, Hierck B, et al. (2007) Large variations in absolute wall shear stress levels within one species and between species. Atherosclerosis 195: 225-235. (Pubitemid 350087951)
73. Meiklejohn DJ, Urbaniak SJ, Greaves M (1999) Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): no association with platelet fibrinogen binding. Br J Haematol 105: 664-666. (Pubitemid 29277021)
74. Feng DL, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, et al. (1999) Increased platelet aggregability associated with platelet GPIII alpha Pl(A2) polymorphism - The Framingham Offspring Study. Arteriosclerosis Thrombosis and Vascular Biology 19: 1142-1147. (Pubitemid 29177367)
75. Pongrácz E, Schweitzer K, Fürész J, Fent J, Tordai A, et al. (2007) The effects of platelet receptor GPIIb/IIIa polymorphism (Leu Pro33) on the receptor expression and platelet aggregation in patients with ischaemic stroke. Turkish Journal of Haematology 24: 155-163.
76. Floyd CN, Ferro A (2013) The PlA1/A2 Polymorphism of Glycoprotein IIIa in Relation to Efficacy of Antiplatelet Drugs: a Systematic Review and Meta-analysis. Br J Clin Pharmacol.
77. Undas A, Brummel K, Musial J, Mann KG, Szczeklik A (2001) PIA2 polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 104: 2666-2672. (Pubitemid 33108131)
78. Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W (2000) Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 110: 965-967.
79. Morawski W, Sanak M, Cisowski M, Szczeklik M, Szczeklik W, et al. (2005) Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism. J Thorac Cardiovasc Surg 130: 791-796. (Pubitemid 41265721)
80. Park HJ, Cho HJ, Kim YD, Lee DW, Choi HY, et al. (2009) Comparison of the characteristics for in-hospital and out-of-hospital ischaemic strokes. Eur J Neurol 16: 582-588.
81. Mikkelsson J, Perola M, Laippala P, Penttila A, Karhunen PJ (2000) Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death. J Am Coll Cardiol 36: 1317-1323.
82. Carter AM, Catto AJ, Bamford JM, Grant PJ (1999) Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke. Stroke 30: 2606-2611.